Back to Dashboard
RME · Unknown

RESMED INC

USA Unknown Filing: 2025-12-31
Smart-money confidence · 1 of 3 sources firing
Bearish — money moving out

No standout activity across the feeds we track.

Hedge funds
32
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
◆ Next steps Interested in RESMED INC? Here's what to do with it.
Not financial advice. Bogen Capital surfaces public SEC filings — you decide what to do with them.
Who's behind the signal
Every informed buyer we can see on RME, across all three feeds.
Hedge funds · 6
AQR Capital Management Increased +15%
Citadel Advisors Decreased −66%
D.E. Shaw & Co Decreased −5%
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Not a model pick — but on our radar. RESMED INC isn't in the top-10 model right now, but 6 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
6
Investors
0
New positions
4
Increasing
2
Decreasing
0
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.1×
Increased +70%
% of portfolio
0.1%
Position change
+70%
0.1% of Gotham Asset Mgmt's portfolio
Trust weight: 1.3×
Increased +3%
% of portfolio
0.0%
Position change
+3%
0.0% of Bridgewater Associates's portfolio
Trust weight: 1.0×
Increased +15%
% of portfolio
0.0%
Position change
+15%
0.0% of AQR Capital Management's portfolio
Trust weight: 1.0×
Increased +32%
% of portfolio
0.0%
Position change
+32%
0.0% of Millennium Management's portfolio
Trust weight: 1.0×
Decreased −66%
% of portfolio
0.0%
Position change
−66%
0.0% of Citadel Advisors's portfolio
Trust weight: 1.0×
Decreased −5%
% of portfolio
0.0%
Position change
−5%
0.0% of D.E. Shaw & Co's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to RESMED INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell RESMED INC or any security.

Get the Weekly Update

Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime